Brenda Hoffman to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Brenda Hoffman has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.221
-
Modeling rectal cancer to advance neoadjuvant precision therapy. Int J Cancer. 2020 09 01; 147(5):1405-1418.
Score: 0.133
-
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
Score: 0.088